Pathology
 |
|
11 march 2021 00:47:43 |
| Low-dose amikacin in the treatment of Multidrug-resistant Tuberculosis (MDR-TB) (BMC Infectious Diseases) |
|
Tweet The World Health Organization recommends intravenous amikacin for the treatment of MDR-TB at a dose of 15 mg/kg. However, higher doses are associated with significant toxicity. |
| 216 viewsCategory: Immunology, Pathology |
 Molecular investigation of an outbreak associated with total parenteral nutrition contaminated with NDM-producing Leclercia adecarboxylata (BMC Infectious Diseases)Chronic maternal hepatitis B virus infection and pregnancy outcome- a single center study in Kunming, China (BMC Infectious Diseases) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
